Skip to content
Saleshttps://cannpal.com
+61(2)61083622 Ph: +61 (2) 6108 3622
CannPalCannPal Animal Healthinfo@cannpal.com+61(2)6108362249https://cannpal.com
CannPal Logo
Home About Contact Resource Centre
Investor News
September 5, 2018

CannPal Commences Phase 1B Study for Lead Drug Candidate CPAT-01D

Read More
August 8, 2018

CannPal Enters MOU with The University of Melbourne to Research Epilepsy Treatment for Dogs

Read More
August 2, 2018

CannPal Receives Ethics Approvals for Phase 1B Study in Dogs

Read More
July 8, 2018

CannPal Enters into Research Agreement with Eurofins Animal Health for Cat Drug

Read More
June 28, 2018

CannPal Receives Funding for Research Collaboration with CSIRO

Read More
June 18, 2018

Market Update on CPAT-01 & Pharmacokinetic Study

Read More

Posts pagination

Page 1 Page 2 Next page

  • SUBSCRIBE

  • This field is for validation purposes and should be left unchanged.

Invest in CannPal

CannPal Animal Therapeutics Limited (“CannPal”) is a pharmaceutical-focused animal health company researching the benefits of medical cannabis for companion animals. The company is listed on the Australian Stock Exchange (ASX) in 2017, trading under the ASX ticker “CP1”. CannPal was founded to research, develop and commercialise, regulatory approved medicines derived from the medical cannabis plant to provide veterinarians with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.

Learn More

CannPal Logo
info@cannpal.com +61 (2) 6108 3622 Privacy Policy
Copyright © CannPal 2025. All rights reserved. Designed and Developed by Web Bird Digital

Sorry to interrupt

Want to be the first to know about the latest developments in the animal cannabinoid therapeutics industry?

Sign up to our monthly newsletter to keep up-to-date!

  • SUBSCRIBE

  • This field is for validation purposes and should be left unchanged.

View our Privacy Policy